Study: Wider generic use would save Part D program billions
By
Haymarket Media
Jan 25, 2007
Increasing the dispensing rates for generic drugs among Part D beneficiaries could save billions of dollars, a pharmaceutical industry study found.
Generic drug use saves money in Part D program, studies find
By
Haymarket Media
Mar 06, 2006
Medicare beneficiaries who use generic medications in the new prescription drug plan can significantly cut costs, according to separate studies by the Consumers Union, and the Centers for Medicare & Medicaid.
Generic but not simple
By
John Hall
Oct 06, 2017
Pharmacists view new generics wave with caution, urge close look at regimens
Certain female carriers of Alzheimer’s gene have faster decline than males: study
By
Alicia Lasek
Nov 22, 2022
Women who carry the APOE e4 gene and develop early-onset Alzheimer’s disease may have quicker cognitive decline than men with these attributes, a new study has found.
Omnicare and McKesson expand agreement
Nov 25, 2014
Omnicare Inc. and McKesson Corporation have signed an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals.
Vitamin D may protect against Alzheimer’s, new report asserts
By
Alicia Lasek
Mar 06, 2023
Exposure to vitamin D supplements is linked to longer dementia-free survival and a lower rate of dementia when compared to no exposure, a new study has found.
Therapy dog brings smiles and smooches to Illinois facility
By
Foster Stubbs
Mar 28, 2023
Dr. Grizzly Bear, a 4-year-old goldendoodle, didn’t go to medical school but he’s earned his title. And he may not prescribe pills but his presence provides plenty of good medicine to residents...
Popular Alzheimer’s drug to remain on the market at least until August
By
John Hall
May 27, 2015
A federal appeals court has temporarily thwarted a drug company’s plan to replace a proven Alzheimer’s drug with a more expensive version.
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.
FDA approves first generic of glucagon to treat severe low blood sugar
By
Alicia Lasek
Jan 04, 2021
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.